Perez 2019a - Revision history

Scipediacontent at 14:04, 23 September 2019

2019-09-23T14:04:24Z

Show changes

Juan-Manuel-Pérez-Agudelo at 02:27, 3 June 2019

2019-06-03T02:27:58Z

Juan-Manuel-Pérez-Agudelo: Juan-Manuel-Pérez-Agudelo moved page Draft Perez 576845196 to Perez 2019a

2019-06-03T02:24:52Z

Juan-Manuel-Pérez-Agudelo moved page Draft Perez 576845196 to Perez 2019a

Juan-Manuel-Pérez-Agudelo at 16:25, 31 May 2019

2019-05-31T16:25:41Z

Show changes

Juan-Manuel-Pérez-Agudelo at 16:20, 31 May 2019

2019-05-31T16:20:13Z

Show changes

Juan-Manuel-Pérez-Agudelo at 16:18, 31 May 2019

2019-05-31T16:18:16Z

Juan-Manuel-Pérez-Agudelo at 16:16, 31 May 2019

2019-05-31T16:16:59Z

Juan-Manuel-Pérez-Agudelo: Created page with "==1 Title, abstract and keywords

← Older revision		Revision as of 02:27, 3 June 2019
Line 92:		Line 92:
	You should ensure that all references are cited in the text and that the reference list. References should preferably refer to documents published in Scipedia. Unpublished results should not be included in the reference list, but can be mentioned in the text. The reference data must be updated once publication is ready. Complete bibliographic information for all cited references must be given following the standards in the field (IEEE and ISO 690 standards are recommended). If possible, a hyperlink to the referenced publication should be given. See examples for Scipedia’s articles [1], other publication articles [2], books [3], book chapter [4], conference proceedings [5], and online documents [6], shown in references section below. -->==		You should ensure that all references are cited in the text and that the reference list. References should preferably refer to documents published in Scipedia. Unpublished results should not be included in the reference list, but can be mentioned in the text. The reference data must be updated once publication is ready. Complete bibliographic information for all cited references must be given following the standards in the field (IEEE and ISO 690 standards are recommended). If possible, a hyperlink to the referenced publication should be given. See examples for Scipedia’s articles [1], other publication articles [2], books [3], book chapter [4], conference proceedings [5], and online documents [6], shown in references section below. -->==

−
−
−
−	~~==4 Acknowledgments<!-- Acknowledgments should be inserted at the end of the document, before the references section. -->==~~

@@ Line 1: / Line 1: @@
 PHARMACOEPIDEMIOLOGY AND BIOINFORMATICS: EVOLUTION AND INTEGRATION OF ANALYTICAL WAYS ON PRECISION THERAPEUTICS ON CARDIOVASCULAR RISK
 ABSTRACT
 The pharmacological intervention is positioned as a common element in the process of approaching patients at different levels of care, with the aim of limiting the natural evolution of various pathological conditions, generating symptomatic relief, preventing and in some circumstances, diagnosing. The use of therapeutic molecules within the framework of clinical decisions requires the conjunction and analysis of elements such as pharmacological, regulatory, epidemiological knowledge and individual characterization of the patient. This complex and multivariable scenario implies an important effort of the health professional, who will also find himself with a systematic element in front of the exposure to drugs: the adverse drug reactions, unwanted and within the therapeutic spectrum. To support the professional in the area of health sciences, bioinformatics and biostatistical information analysis processes arise, techniques that together with the advance in omics sciences, allow to describe, generate inference, explain, predict and apply knowledge of the science of data, at the bedside of the patient. The incorporation of bioinformatics and pharmacological analysis in complex levels of health care, with special reference to cardiovascular drugs, would allow to anticipate problems derived from interactions, indications, use, compliance and clinical impact.
 Keywords: Cardiovascular drugs, database, computational biology, medical informatics, analytical epidemiology, pharmacogenomics

@@ Line 1: / Line 1: @@
-==1 Title, abstract and keywords<!-- Your document should start with a concise and informative title. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible. Capitalize the first word of the title.
+PHARMACOEPIDEMIOLOGY AND BIOINFORMATICS: EVOLUTION AND INTEGRATION OF ANALYTICAL WAYS ON PRECISION THERAPEUTICS ON CARDIOVASCULAR RISK
+ABSTRACT
-Provide a maximum of 6 keywords, and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field should be used. These keywords will be used for indexing purposes.
+The pharmacological intervention is positioned as a common element in the process of approaching patients at different levels of care, with the aim of limiting the natural evolution of various pathological conditions, generating symptomatic relief, preventing and in some circumstances, diagnosing. The use of therapeutic molecules within the framework of clinical decisions requires the conjunction and analysis of elements such as pharmacological, regulatory, epidemiological knowledge and individual characterization of the patient. This complex and multivariable scenario implies an important effort of the health professional, who will also find himself with a systematic element in front of the exposure to drugs: the adverse drug reactions, unwanted and within the therapeutic spectrum. To support the professional in the area of health sciences, bioinformatics and biostatistical information analysis processes arise, techniques that together with the advance in omics sciences, allow to describe, generate inference, explain, predict and apply knowledge of the science of data, at the bedside of the patient. The incorporation of bioinformatics and pharmacological analysis in complex levels of health care, with special reference to cardiovascular drugs, would allow to anticipate problems derived from interactions, indications, use, compliance and clinical impact.
+Keywords: Cardiovascular drugs, database, computational biology, medical informatics, analytical epidemiology, pharmacogenomics
-An abstract is required for every document; it should succinctly summarize the reason for the work, the main findings, and the conclusions of the study. Abstract is often presented separately from the article, so it must be able to stand alone. For this reason, references and hyperlinks should be avoided. If references are essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. -->==
-−
-−
-−
 ==2 The main text<!-- You can enter and format the text of this document by selecting the ‘Edit’ option in the menu at the top of this frame or next to the title of every section of the document. This will give access to the visual editor. Alternatively, you can edit the source of this document (Wiki markup format) by selecting the ‘Edit source’ option.

← Older revision	Revision as of 02:24, 3 June 2019
(No difference)